Moore, Troy AlanSchool of Medicine |
|
|
Psychopharmacologist with interests in schizophrenia, medication management, dual diagnosis, substance abuse, and outcomes research. |
|
| 10/2010 - Present | Clinical Pharmacy Specialist- Psychiatry | South Texas Veterans Health Care System, Pharmacy, San Antonio, TX |
| 1/2008 - Present | Adjunct Clinical Professor | The University of Texas at Austin, Austin, TX |
| 9/2007 - Present | Assistant Professor | The University of Texas Health Science Center at San Antonio, Psychiatry, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 2005 | MS | Pharmacy | The University of Texas at Austin Austin , TX |
| 2005 | Residency | Psychiatric Pharmacy | The University of Texas at Austin and the South Texas Veterans HCS Austin/San Antonio , TX |
| 2003 | PharmD | Pharmacy | The University of New Mexico Albuquerque , NM |
Psychopharmacology- Clinical pharmacist with training emphasizing in psychiatric pharmacy |
| Date | Description | Institution | # Students |
| 4/2013 - Present | Post-Doctoral Student Supervision | South Texas Veterans Health Care System | |
| 8/2011 - Present | Rotation Student Supervision | The University of Texas at Austin College of Pharmacy | |
| 5/2008 - Present | PGY-II Psychiatric Resident Schizophrenia Seminar Series | UTHSCSA | 12 students |
| Lecture on the evidence-based practices of antipsychotic medication | |||
| 5/2007 - Present | Fundamentals of Neuroscience II | The University of Texas Health Science Center | 4 students |
| Provided lecture to neuroscience graduate students on antipsychotic pharmacology | |||
Journal Article |
| Maples NJ, Copeland LA, Zeber JE, Li X, Moore TA, Dassori A, Velligan DI, Miller AL. Can medication management coordinators help improve continuity of care after psychiatric hospitalization? Psychiatr Serv 2012 Jun;63(6):554-560. |
| Velligan DI, Medellin EM, Draper ML, Maples NJ, Dassori AM, Moore TA, Lopez L. Barriers to, and Strategies for, Starting a Long Acting Injection Clinic in a Community Mental Health Center (in press) Community Mental Health Journal 2011 Dec;:654-659. |
| Gonzalez JM, Thompson PM, Moore TA. Review of the safety, efficacy and side effect profile of asenapine in the treatment Patient Preference and Adherence 2011 Jul;2011(5):333-341. |
| Moore TA, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Essock SM, Finnerty M, Marder SR, Miller del D, McEvoy JP, Robinson DG, Schooler NR, Shon SP, Stroup TS, Miller AL. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update Journal of Clinical Psychiatry 2007 Nov;68(11):1751-1762. |
| Moore TA, Covell NH, Essock SM, Miller AL. Real-World Antipsychotic Treatment Practices Psychiatric Clinics of North America 2007 Sep;30(3):401-416. |
Book Chapter |
| Moore TA, Kuipers E, Miller AL. Producing guidelines, protocols and toolkits. In: Szmukler G, Mueser K, Drake RE, Thornicroft G. Oxford Textbook of Community Mental Health. Oxford: Oxford University Press; 2011. |
| Mascarenas CA, Moore TA. Depression. In: Linn WD, Wofford M, OKeefe ME, Posey LM eds. Pharmacotherapy in Primary Care. New York: McGraw-Hill; 2008. |
Abstract |
| Velligan DI, Medellin EM, Castillo DA, Moore TA, Li X, Miller AL. VISTA: A novel psychosocial treatment to improve metabolic risk factors for patients on atypical antipsychotics Abstract for the 13th International Congress on Schizophrenia Research (ICOSR); 2011 Mar. (Schizophrenia Bulletin). |
| Moore TA, Miller AL, Lopez L, Castillo D, Mintz J, Muenzler K, Li X, Pace P. High Utilizers of Inpatient State Hospital Services; 2009 Mar. (Schizophrenia Bulletin; vol. 35, no. 1). |
| Miller AL, Velligan DI, Maples NJ, Li X, Copeland LA, Dassori AM, Moore TA, Mintz J, Zeber JE, Boone C, Evans L, Rodriguez J. Continuity of Care After Psychiatric Hospitalization; 2009 Jan. (Schizophrenia Bulletin; vol. 35, no. 1). |
Review Article |
| Moore TA. Schizophrenia Treatment Guidelines in the United States Clinical Schizophrenia & Related Psychoses 2011 Apr;5(1):40-49. |
Electronic/Web Publication |
| Argo TR, Crismon ML, Miller A, Moore TA, Bendele SD, Suehs B. Texas Medication Algorithm Project Procedural Manual: Schizophrenia Manual Austin, TX: Texas Department of State Health Services; 2008 Jun. 65 p. |
Federal |
|
| Funding Agency | NIMH |
| Title | Sustaining Public Academic Research Collaborations. |
| Status | Complete |
| Period | 3/2006 - 2/2012 |
| Role | Co-Investigator |
| Grant Detail | The objective of this project is to create infrastructure for an interventions research partnership of investigators between the University of Texas Health Science Center and the Center of Health Care Services. |
| Funding Agency | Social Security Administration-subcontract with Dartmouth |
| Title | Mental Health Treatment Study |
| Status | Complete |
| Period | 10/2005 - 5/2011 |
| Role | Co-Investigator |
| Grant Detail | This is a study of the effects on employment and resource utilization of providing supported employment services at 20 sites for 1500 patients on disability for schizophrenia, bipolar disorder, or major depressive disorder. Westat is subcontracting with Dartmouth Univ. (Robert Drake, PI) which in turn is subcontracting with UTHSCSA(Alexander L. Miller, Co-Investigator) to provide medication management guidelines and consultations to nurse care coordinators who provide recommendations to prescribers seeing study participants. |
